EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

TSPO ‐ PET in pre‐surgical evaluations: Correlation of neuroinflammation and SEEG epileptogenicity mapping in drug‐resistant focal epilepsy

Jennifer Kilmer, Sebatian Rodrigo, Ana-Maria Petrescu, Nozar Aghakhani, Anne Herbrecht, Claire Leroy, Nicolas Tournier, Michel Bottlaender, Delphine Taussig, Viviane Bouilleret iD

Epilepsia · 2025-02 · 66 (2) · 430-443

DOI: 10.1111/epi.18182 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, online erschienen am 16.12.2024. Verfasst von Jennifer Kilmer und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire d'Imagerie Biomédicale Multimodale (BioMaps), Service Hospitalier Frédéric Joliot, Université Paris-Saclay, CEA, CNRS, Inserm, Orsay, Fra…. Hauptthemen laut MEDLINE: Drug Resistant Epilepsy, Positron-Emission Tomography, Epilepsies, Partial, Receptors, GABA. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fondation française pour la Recherche sur l'Epilepsie.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Resective surgery in drug‐resistant focal epilepsy (DRFE) requires extensive evaluation to localize the epileptogenic zone (EZ). When non‐invasive phase 1 assessments (electroencephalography, EEG; magnetic resonance imaging, MRI; and 18 F‐Fluorodeoxyglucose–positron emission tomography, [ 18 F]FDG‐PET) are inconclusive for EZ localization, invasive investigations such as stereo‐EEG (SEEG) are necessary. Epileptogenicity maps (Ems) visualize the EZ using SEEG‐identified ictal high‐frequency oscillations (iHFOs). PET imaging with radioligands targeting the18‐kDa translocator protein (TSPO), a marker of glial activation, may aid EZ localization. This study investigates the correlation between TSPO‐PET imaging and SEEG iHFOs in DRFE to determine the utility of TSPO‐PET in pre‐surgical assessments, especially in complex or non‐lesional cases.

Methods

Patients with DRFE and inconclusive phase 1 assessments were recruited from Bicêtre Hospital (AP‐HP) for a prospective study (Eudract 2017–003381‐27). They underwent SEEG and [ 18 F]DPA‐714 (N,N‐diethyl‐2‐(2‐(4‐(2‐(fluoro‐ 18 F)ethoxy)phenyl)‐5,7‐dimethylpyrazolo[1,5‐a]pyrimidin‐3‐yl)acetamide) (TSPO radioligand) PET imaging. Statistical parametric mapping (SPM) techniques analyzed significant [ 18 F]DPA‐714‐PET uptake (TSPO‐map) and generated epileptogenicity maps (EM‐map). Correlation analyses at regional and voxel‐of‐interest (VOI) levels assessed the relationship between TSPO‐map and EM‐map.

Results

We were able to obtain and analyze both maps in 12 of 17 patients recruited. A significant positive correlation between EM‐map and TSPO‐map in focal epilepsies was found regionally ( r = .81, p < .00004) and at the VOI level ( r = .79, p < .00003). Temporal, insular, parietal, and occipital regions showed particularly strong correspondence. In frontal epilepsies, TSPO‐map was more focal than EM‐map, suggesting increased specificity for SEEG planning. This study also demonstrated the benefit of the TSPO‐map in identifying multiple foci in multifocal epilepsies, with or without lesions. Significance These findings suggest that neuroinflammation may be a molecular substrate of the EZ in non‐lesional focal epilepsy. Identifying the EZ inpatients with complex DRFE and inconclusive MRI/[ 18 F]FDG‐PET imaging is essential to improve resective surgery outcomes. Combining TSPO‐PET imaging with SEEG recordings may help bridge this gap.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistant EpilepsyPositron-Emission TomographyEpilepsies, PartialReceptors, GABAElectroencephalographyNeuroinflammatory DiseasesHumansFemaleMaleAdultMiddle AgedYoung AdultBrain MappingAdolescentMagnetic Resonance ImagingStereotaxic Techniques

Stichwörter der Autor:innen

TSPO‐PETdrug‐resistant epilepsyepilepsy surgeryepileptogenicity mapsneuroinflammationstatistical parametric mapping

Substanzen

TSPO protein, humanReceptors, GABA

Autor:innen und Institutionen

  • Laboratoire d'Imagerie Biomédicale Multimodale (BioMaps), Service Hospitalier Frédéric Joliot, Université Paris-Saclay, CEA, CNRS, Inserm, Orsay, France.
  • Neurophysiology and Epileptology Department, Hôpital Bicêtre, Assistance Publique des Hôpitaux de Paris (AP-HP), Université Paris-Saclay, Orsay, France.
  • Department of Neurosurgery, Hôpital Bicêtre, Assistance Publique des Hôpitaux de Paris (AP-HP), Université Paris-Saclay, Orsay, France.
  • School of Medicine, Université Paris Saclay, Le Kremlin-Bicêtre, France.

ORCID-Profile: Viviane Bouilleret

Förderung

  • Fondation française pour la Recherche sur l'Epilepsie

Zitieren

APA

Kilmer, J., Rodrigo, S., Petrescu, A. M., Aghakhani, N., Herbrecht, A., Leroy, C., Tournier, N., Bottlaender, M., Taussig, D., & Bouilleret, V. (2025). TSPO ‐ PET in pre‐surgical evaluations: Correlation of neuroinflammation and SEEG epileptogenicity mapping in drug‐resistant focal epilepsy. Epilepsia, 66(2), 430-443. https://doi.org/10.1111/epi.18182

Vancouver

Kilmer J, Rodrigo S, Petrescu AM, Aghakhani N, Herbrecht A, Leroy C, et al. TSPO ‐ PET in pre‐surgical evaluations: Correlation of neuroinflammation and SEEG epileptogenicity mapping in drug‐resistant focal epilepsy. Epilepsia. 2025;66(2):430-443. doi:10.1111/epi.18182

BibTeX
@article{Kilmer2025,
  author = {Kilmer, Jennifer and Rodrigo, Sebatian and Petrescu, Ana-Maria and Aghakhani, Nozar and Herbrecht, Anne and Leroy, Claire and Tournier, Nicolas and Bottlaender, Michel and Taussig, Delphine and Bouilleret, Viviane},
  title = {TSPO ‐ PET in pre‐surgical evaluations: Correlation of neuroinflammation and SEEG epileptogenicity mapping in drug‐resistant focal epilepsy},
  journal = {Epilepsia},
  year = {2025},
  volume = {66},
  number = {2},
  pages = {430--443},
  doi = {10.1111/epi.18182}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche